long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
Peterson LB., Bell CJM., Howlett SK., Pekalski ML., Brady K., Hinton H., Sauter D., Todd JA., Umana P., Ast O., Waldhauer I., Freimoser-Grundschober A., Moessner E., Klein C., Hosse RJ., Wicker LS.